A case of MPO- and PR3-ANCA-positive hypertrophic cranial pachymeningitis with elevated serum IgG4

Modern Rheumatology

Volumn 23, Issue 1, 2013, Pages 151-155

  Iguchi, Akira ^a,b,c   Wada, Yoko ^a,b,c   Kobayashi, Daisuke ^a,b,c   Sato, Hiroe ^a,b,c   Oyama, Tokuhide ^a,b,c   Nakatsue, Takeshi ^a,b,c   Murakami, Shuichi ^a,b,c   Kuroda, Takeshi ^a,b,c   Nakano, Masaaki ^a,b,c   Narita, Ichiei ^a,b,c  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

ANCA; Cyclophosphamide; IgG4; Orbital tumor; Pachymeningitis

Indexed keywords

CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOGLOBULIN G4; METHYLPREDNISOLONE; MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RHEUMATOID FACTOR;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DURA MATER; ENCEPHALITIS; EXOPHTHALMOS; FEMALE; HUMAN; HUMAN TISSUE; HYPERTROPHIC CRANIAL PACHYMENINGITIS; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT TUMOR; PAPILLEDEMA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT RESPONSE; TRIGEMINAL NERVE DISEASE; TUMOR BIOPSY; VISUAL ACUITY; VISUAL DISORDER; VISUAL IMPAIRMENT;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTERIES; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; DURA MATER; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MENINGITIS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; ORBITAL NEOPLASMS; PEROXIDASE; RUPTURE; TREATMENT OUTCOME;

EID: 84872485264     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0613-1     Document Type: Article

References (18)

1. Rojana-Udomsart A, Pulkes T, Viranuwatti K, Laothamatas J, Phudhichareonrat S, Witoonpanich R. Idiopathic hypertrophic cranial pachymeningitis. J Clin Neurosci. 2008;15:465-9.
2. Horino T, Takao T, Taniguchi Y, Terada Y. Hypertrophic pachymeningitis with MPO-ANCA-positive vasculitis. Clin Rheumatol. 2010;29:111-3.
3. Chan SK, Cheuk W, Chan KT, Chan JK. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol. 2009;33:1249-52.
4. Choi SH, Lee SH, Khang SK, Jeon SR. IgG4-related sclerosing pachymeningitis causing spinal cord compression. Neurology. 2010;75:1388-90.
5. Kosakai A, Ito D, Yamada S, Ideta S, Ota Y, Suzuki N. A case of definite IgG4-related pachymeningitis. Neurology. 2010;75:1390-2.
6. Lindstrom KM, Cousar JB, Lopes MBS. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol. 2010;120:765-76.
7. Nagashima T, Maguchi S, Terayama Y, Horimoto M, Nemoto M, Nunomura M, et al. P-ANCA-positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: case report and review of literature. Neuropathology. 2000;20:23-30.
8. Saeki T, Fujita N, Kourakata H, Yamazaki H, Miyamura S. Two cases of hypertrophic pachymeningitis associated with myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA)-positive pulmonary silicosis in tunnel workers. Clin Rheumatol. 2004;23:76-80.
9. Sharma A, Kumar S, Wanchu A, Lal V, Singh R, Gupta V, et al. Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab. Clin Rheumatol. 2010;29:107-10.
10. Di Comite G, Bozzolo EP, Praderio L, Tresoldi M, Sabbadini MG. Meningeal involvement in Wegener's granulomatosis is associated with localized disease. Clin Exp Rheumatol. 2006;24:S60-4.
11. Saeki T, Saito A, Hiura T, Yamazaki H, Emura I, Ueno M, et al. Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med. 2006;45:163-7.
12. Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2008;68:1310-5.
13. Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2011 (in press).
14. Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, et al. Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991;83:379-86.
15. Sato Y, Ohshima K, Ichimura K, Sato M, Yamadori I, Tanaka T, et al. Ocular adnexal IgG4-related disease has uniform clinicopathology. Pathol Int. 2008;58:465-70.
16. Tarabishy AB, Schulte M, Papaliodis GN, Hoffman GS. Wegener's granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol. 2010;55:429-44.
17. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localized non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J Clin Pathol. 2011;64:237-43.
18. Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, et al. Diagnosis of IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol. 2011;22:1343-52.